Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway

Inhibition of microglia activation may provide therapeutic treatment for many neurodegenerative diseases. Astragaloside IV (ASI) with anti-inflammatory properties has been tested as a therapeutic drug in clinical trials of China. However, the mechanism of ASI inhibiting neuroinflammation is unknown....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Sci Rep
Egile Nagusiak: Liu, Hong-Shuai, Shi, Hai-Lian, Huang, Fei, Peterson, Karin E., Wu, Hui, Lan, Yun-Yi, Zhang, Bei-Bei, He, Yi-Xin, Woods, Tyson, Du, Min, Wu, Xiao-Jun, Wang, Zheng-Tao
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4707476/
https://ncbi.nlm.nih.gov/pubmed/26750705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep19137
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak